Search results
Results from the WOW.Com Content Network
Lambda phage is a non-contractile tailed phage, meaning during an infection event it cannot 'force' its DNA through a bacterial cell membrane. It must instead use an existing pathway to invade the host cell, having evolved the tip of its tail to interact with a specific pore to allow entry of its DNA to the hosts.
A cosmid is a type of hybrid plasmid that contains a Lambda phage cos sequence. [1] Often used as cloning vectors in genetic engineering, cosmids can be used to build genomic libraries. They were first described by Collins and Hohn in 1978. [2] Cosmids can contain 37 to 52 (normally 45) kb of DNA, limits based on the normal bacteriophage ...
In the lambda phage, it is specifically E. coli. The wild type, having a temperate life cycle, allows the virus to exist in 2 life cycle stages, A lysogeny, and a lytic stage. During these life cycles it destroys the cell through the process of lysis, during the lysis process the offspring of the virus are released from the burst cell.
Such factors include temperature, [14] cellular starvation and number of phage infecting the cell (an indication of population number of phage). [4] Experiments have shown that low temperatures increase the in vivo half-life of cII from ~1-2 mins at 37˚C to 20 mins at 20˚C, thus increasing the probability of a cell to lysogenize.
Lambdavirus (synonyms Lambda-like viruses, Lambda-like phages, Lambda phage group, Lambda phage) is a genus of viruses in the order Caudovirales, in the family Siphoviridae. Bacteria serve as natural hosts, with transmission achieved through passive diffusion. There are five species in this genus.
This sequence allows the cosmid to be packaged into bacteriophage λ particles. These particles- containing a linearized cosmid- are introduced into the host cell by transduction. Once inside the host, the cosmids circularize with the aid of the host's DNA ligase and then function as plasmids. Cosmids are capable of carrying inserts up to 40kb ...
Phage display of antibody libraries has become a powerful method for both studying the immune response as well as a method to rapidly select and evolve human antibodies for therapy. Antibody phage display was later used by Carlos F. Barbas at The Scripps Research Institute to create synthetic human antibody libraries, a principle first patented ...
The first step in Gateway cloning is the preparation of a Gateway Entry clone. There are a few different ways to make entry clone. Gateway attB1 and attB2 sequences are added to the 5' and 3' end of a gene fragment, respectively, using gene-specific PCR primers and PCR amplification. The PCR amplification products are then mixed with a propriet